ビルダグリプチン
1. VildagliptinVildagliptin (previously identified as LAF237, trade names Zomelis, Galvus) is an oral anti-hyperglycemic agent of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas.
Read “Vildagliptin” on English Wikipedia
Read “ビルダグリプチン” on Japanese Wikipedia
Read “Vildagliptin” on DBpedia
Read “Vildagliptin” on English Wikipedia
Read “ビルダグリプチン” on Japanese Wikipedia
Read “Vildagliptin” on DBpedia
Discussions
Log in to talk about this word.